Mucosal effector memory CD8 T cells (TEM) are located at mucosal epithelium and have a heightened and immediate effector function. By contrast, memory T cells residing within lymphoid tissues and require proliferation and differentiation to become effector cells that migrate to epithelial surfaces. The accumulation of TEM at the pathogen entry site(s) is essential for protective immunity, but the mechanisms that drive the differentiation of mucosal memory cells are poorly understood. Our preliminary data indicate that activation-induced CD8aa, induced by high affinity/avidity TCR signals, might selectively rescue thymocytes and mature CD8 T cells from activation induced cell death (AICD) allowing them to become memory T cells. Furthermore, our data also suggest that the high-affinity CD8aa ligand, the mouse thymus leukemia (TL) antigen, induced on some APCs and constitutively expressed on intestinal epithelial cells, might serve as a second selective key component to assure the long-term accumulation of the fittest effector cells (CD8aa+) to form mucosal TEM. The current proposal is designed to provide solid evidence for these exciting, breakthrough and highly significant initial observations.

Public Health Relevance

The continued failure of HIV vaccination trials is a clear warning that the vaccination approaches used so far do not reproduce natural immunity that controls the virus in natural HIV resistant people. They also signify a serious need for a better understanding and characterization of mechanisms and factors that drive natural memory and that could be applied to direct effective vaccine-induced protective immunity. It is therefore of utmost importance to understand and identify the mechanisms and factors that can direct vaccine-induced differentiation and maintenance of highly effective and long-lived immune memory. Our studies so far, suggest that both lymphoid and mucosal memory are required for protection, but that the absence of mucosal immunity leads to a significant impaired immune defense, which might be one of the most significant causes of setbacks in the fierce effort to develop an effective HIV vaccine. Our proposed study aims to investigate a new direction and new insights that we have gained from the previous research, that likely will lead to significant new information important for the design of novel and effective strategies to combat devastating infections and cancers.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI064584-06
Application #
8109135
Study Section
Gastrointestinal Mucosal Pathobiology Study Section (GMPB)
Program Officer
Lapham, Cheryl K
Project Start
2005-03-15
Project End
2016-01-31
Budget Start
2011-02-15
Budget End
2012-01-31
Support Year
6
Fiscal Year
2011
Total Cost
$454,500
Indirect Cost
Name
La Jolla Institute
Department
Type
DUNS #
603880287
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Verstichel, Greet; Vermijlen, David; Martens, Liesbet et al. (2017) The checkpoint for agonist selection precedes conventional selection in human thymus. Sci Immunol 2:
Larange, Alexandre; Cheroutre, Hilde (2016) Retinoic Acid and Retinoic Acid Receptors as Pleiotropic Modulators of the Immune System. Annu Rev Immunol 34:369-94
Vicente-Suarez, I; Larange, A; Reardon, C et al. (2015) Unique lamina propria stromal cells imprint the functional phenotype of mucosal dendritic cells. Mucosal Immunol 8:141-51
Davani, Dariush; Pancer, Zeev; Cheroutre, Hilde et al. (2014) Negative selection of self-reactive chicken B cells requires B cell receptor signaling and is independent of the bursal microenvironment. J Immunol 192:3207-17
Mayans, Sofia; Stepniak, Dariusz; Palida, Sakina et al. (2014) ??T cell receptors expressed by CD4(-)CD8??(-) intraepithelial T cells drive their fate into a unique lineage with unusual MHC reactivities. Immunity 41:207-218
Fu, Guo; Casas, Javier; Rigaud, Stephanie et al. (2013) Themis sets the signal threshold for positive and negative selection in T-cell development. Nature 504:441-5
Walker, L J; Marrinan, E; Muenchhoff, M et al. (2013) CD8?? Expression Marks Terminally Differentiated Human CD8+ T Cells Expanded in Chronic Viral Infection. Front Immunol 4:223
Cheroutre, Hilde; Huang, Yujun (2013) Crosstalk between adaptive and innate immune cells leads to high quality immune protection at the mucosal borders. Adv Exp Med Biol 785:43-7
Steinberg, Marcos W; Huang, Yujun; Wang-Zhu, Yiran et al. (2013) BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infection. PLoS One 8:e77992
Shui, Jr-Wen; Larange, Alexandre; Kim, Gisen et al. (2012) HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria. Nature 488:222-5

Showing the most recent 10 out of 15 publications